The Current Treatment Landscape for Relapsed/Refractory Multiple Myeloma
Amrita Y. Krishnan, MD, and Binod Dhakal, MD, provide an overview of the current treatment landscape in relapsed/refractory multiple myeloma.
Advocate Outlines Resources for Chronic Myeloid Leukemia Population
Advocacy groups such as Cancer Support Community and the Leukemia & Lymphoma Society may help support patients with CML undergoing treatment.
Assessing the Future With “Promising” Antibody Drug Conjugates in Breast Cancer
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Mitigating ILD Following T-DXd in HR+, HER2-Low Metastatic Breast Cancer
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Exciting Developments in Relapsed/Refractory Multiple Myeloma
The panel concludes the discussion by offering future perspectives on the evolving treatment landscape in multiple myeloma, highlighting exciting developments and ongoing research.
Expert Highlights Risk Factors for Disease Progression in Polycythemia Vera
Data from the REVEAL study affirm elevated white blood cell counts and higher variant allele frequency as risk factors for progression in polycythemia vera.
Triaging and Prioritizing Patients with Multiple Myeloma
Experts on multiple myeloma provide clinical insights on how they triage and prioritize patients to best utilize available resources.
CAR T-Cell Therapy: Leukapheresis Practices
Myeloma specialists discuss their approaches to determining the optimal timing for leukapheresis for patients awaiting CAR T-cell therapy.
Patient Profile 2: Managing ICANS Following CAR T-Cell Therapy
Donna Catamero, ANP-BC, OCN, CCRC, presents the case of a 77-year-old patient who experienced ICANS following CAR T-cell therapy and describes the role of the ICE score.
Strategies to Manage or Mitigate CRS
Experts on multiple myeloma provide clinical insights on strategies to manage or mitigate CRS, highlighting premedications, the role of bridging therapy, and potential treatment strategies.
Continued Quizartinib May Show Benefit in Select FLT3-ITD+ AML Population
Additional analyses of patient-reported outcomes and MRD status in the QuANTUM-First trial are also ongoing, says Harry P. Erba, MD, PhD.
“Promising” Data Support Blinatumomab in CD19+ B-ALL Population
Overall survival data with blinatumomab in the phase 3 E1910 study may be an “important development” in CD19-positive B-ALL.
Learning the IORT Mechanism, Potential Advantages in Cancer Surgery
Intraoperative radiation therapy may allow surgical and radiation oncologists to collaboratively visualize at-risk areas in patients with cancer.
Experts Highlight Importance of Achieving R0 Resections in Cancer Surgery
Positive margin rates have not appeared to improve for patients with cancer undergoing surgical care based on several prior studies.
Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Ensuring Quality of Life in Chronic Myeloid Leukemia Populations
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
Treatment Considerations and the Role of BCMA-Targeting CAR T in MM
Continuing discussion centered on a patient case, the panel discusses bispecific antibody combinations and the role of BCMA-targeting CAR T-cell therapies in relapsed/refractory multiple myeloma.
Patient Profile: A 60-Year-Old with Stage III KLC MM
Adriana Rossi, MD, presents the case of a 60-year-old patient with stage III kappa light chain multiple myeloma, and members of the panel provide their initial impressions.
Formulating Questions for Clinicians to Understand a CML Diagnosis
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
Balancing a Family and an Emerging Career in Public Health
Public health researchers highlight how they learned to overcome and adapt to disparities observed during their careers.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Amrita Y. Krishnan, MD, and Binod Dhakal, MD")
